Esperion Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2019 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Esperion Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2019 to 2023.
  • Esperion Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 195M shares, a 74.2% increase year-over-year.
  • Esperion Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 103M shares, a 55.3% increase from 2022.
  • Esperion Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 66.4M shares, a 130% increase from 2021.
  • Esperion Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 28.9M shares, a 5.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 103M +36.7M +55.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 66.4M +37.5M +130% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 28.9M +1.43M +5.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-21
2020 27.5M +384K +1.42% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-22
2019 27.1M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.